Certain Sedatives Tied to Breathing Problems in Older COPD Patients
Study author urges caution for doctors prescribing benzodiazepines to this group.
A group of widely used sedatives increases the risk of serious breathing problems in older people with the lung condition called chronic obstructive pulmonary disease (COPD), a new study says.
Benzodiazepines such as lorazepam (Ativan) or alprazolam (Xanax) are commonly prescribed to treat insomnia and anxiety.
For the study, researcher examined the medical records of older adults with COPD in the Canadian province of Ontario. Those who had been newly prescribed a benzodiazepine had a 45 percent increased risk of experiencing breathing problems that required outpatient treatment.
These patients also had a 92 percent greater risk of needing to go to the emergency room for treatment of pneumonia or COPD, and were more likely to be hospitalized for breathing problems, according to the study.
The findings were consistent even after the severity of patients' COPD was taken into account.
"Physicians, when prescribing these pills, need to be careful, use caution and monitor the patients for respiratory side effects," expert said. "Patients also need to watch for respiratory-related symptoms."
Previous research found that 30 percent of older Canadians with COPD are prescribed benzodiazepines.
Source: HealthDay News
- 330 reads
Human Rights
Conscience, Hope, and Action: Keys to Global Peace and Sustainability
Ringing FOWPAL’s Peace Bell for the World:Nobel Peace Prize Laureates’ Visions and Actions
Protecting the World’s Cultural Diversity for a Sustainable Future
The Peace Bell Resonates at the 27th Eurasian Economic Summit
Puppet Show I International Friendship Day 2020